Feldman Andrew D., CEO, PRES, reported an open-market or private sale at Cerebras Systems Inc. involving 600.000000 shares for an estimated $129486.00. Reported holdings after the transaction were 16953.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
CEO, President
The Class B Common Stock is convertible into an equal number of Class A Common Stock at any time, at the Reporting Person's election, and has no expiration date.
The sale reported on this Form 4 represents shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026.
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $199.00 to $199.87, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $200.16 to $201.12, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $201.45 to $202.11, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $202.59 to $203.43, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $203.65 to $204.62, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $206.02 to $206.53, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $207.21 to $208.19, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $208.39 to $209.38, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $209.41 to $210.34, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $210.42 to $211.42, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $211.42 to $212.39, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $212.50 to $213.49, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $213.50 to $214.48, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $214.52 to $215.33, inclusive. Upon request by the staff of the Securities and…
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $215.53 to $216.06, inclusive. Upon request by the staff of the Securities and…
Represents a pro-rata, in-kind distribution not for additional consideration.
The stock option is fully vested and exercisable.
0 other filings
0 recent txs